GEORGE A SCANGOS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GEORGE A SCANGOS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GEORGE A SCANGOS. GEORGE A SCANGOS is Chief Executive Officer in BIOGEN INC. ($IDPH) and Director in AGILENT TECHNOLOGIES INC ($A) and Director in EXELIXIS, INC. ($EXEL) and President and CEO in Vir Biotechnology, Inc. ($VIR).
Latest Insider Trading Transactions of GEORGE A SCANGOS
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, A, IDPH, EXEL, VIR
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 22 2021 | A | AGILENT TECHNOLOGI ... | SCANGOS GEORGE A | Director | Grant | A | 121.59 | 986 | 119,891 | 16,544 | 15.6 K to 16.5 K (+6.34 %) |
Mar 22 2021 | A | AGILENT TECHNOLOGI ... | SCANGOS GEORGE A | Director | Grant | A | 121.59 | 1,850 | 224,947 | 15,558 | 13.7 K to 15.6 K (+13.50 %) |
Feb 18 2021 | VIR | Vir Biotechnology, ... | SCANGOS GEORGE A | President and CEO | Option Exercise | A | 67.38 | 222,000 | 14,958,360 | 222,000 | |
Feb 18 2021 | VIR | Vir Biotechnology, ... | SCANGOS GEORGE A | President and CEO | Grant | A | 0.00 | 111,000 | 0 | 4,609,559 | 4.5 M to 4.6 M (+2.47 %) |
Aug 05 2020 | A | AGILENT TECHNOLOGI ... | SCANGOS GEORGE A | Director | Grant | A | 93.91 | 177 | 16,622 | 28,112 | 27.9 K to 28.1 K (+0.63 %) |
May 20 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 25.96 | 75,000 | 1,947,000 | 714,717 | 789.7 K to 714.7 K (-9.50 %) |
May 15 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | M | 5.82 | 21,686 | 126,213 | 0 | |
May 15 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | M | 4.58 | 30,000 | 137,400 | 0 | |
May 15 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Buy | M | 5.82 | 21,686 | 126,213 | 789,717 | 768 K to 789.7 K (+2.82 %) |
May 15 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Buy | M | 4.58 | 30,000 | 137,400 | 768,031 | 738 K to 768 K (+4.06 %) |
Apr 24 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 26.24 | 15,000 | 393,600 | 738,031 | 753 K to 738 K (-1.99 %) |
Apr 24 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 26.23 | 55,700 | 1,461,011 | 753,031 | 808.7 K to 753 K (-6.89 %) |
Apr 24 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 25.68 | 44,300 | 1,137,624 | 808,731 | 853 K to 808.7 K (-5.19 %) |
Apr 24 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 26.24 | 15,000 | 393,600 | 738,031 | 753 K to 738 K (-1.99 %) |
Apr 24 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 26.23 | 55,700 | 1,461,011 | 753,031 | 808.7 K to 753 K (-6.89 %) |
Apr 24 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 25.68 | 44,300 | 1,137,624 | 808,731 | 853 K to 808.7 K (-5.19 %) |
Apr 22 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 25.05 | 4,200 | 105,210 | 853,031 | 857.2 K to 853 K (-0.49 %) |
Apr 22 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 25.04 | 5,800 | 145,232 | 857,231 | 863 K to 857.2 K (-0.67 %) |
Apr 22 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 24.70 | 5,900 | 145,730 | 863,031 | 868.9 K to 863 K (-0.68 %) |
Apr 22 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 24.07 | 25,600 | 616,192 | 868,931 | 894.5 K to 868.9 K (-2.86 %) |
Apr 22 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 25.05 | 4,200 | 105,210 | 853,031 | 857.2 K to 853 K (-0.49 %) |
Apr 22 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 23.39 | 18,500 | 432,715 | 894,531 | 913 K to 894.5 K (-2.03 %) |
Apr 22 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 25.04 | 5,800 | 145,232 | 857,231 | 863 K to 857.2 K (-0.67 %) |
Apr 22 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 24.70 | 5,900 | 145,730 | 863,031 | 868.9 K to 863 K (-0.68 %) |
Apr 22 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 24.07 | 25,600 | 616,192 | 868,931 | 894.5 K to 868.9 K (-2.86 %) |
Apr 22 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 23.39 | 18,500 | 432,715 | 894,531 | 913 K to 894.5 K (-2.03 %) |
Apr 21 2020 | A | AGILENT TECHNOLOGI ... | SCANGOS GEORGE A | Director | Grant | A | 73.01 | 1,027 | 74,980 | 27,887 | 26.9 K to 27.9 K (+3.82 %) |
Apr 21 2020 | A | AGILENT TECHNOLOGI ... | SCANGOS GEORGE A | Director | Grant | A | 73.01 | 3,081 | 224,941 | 26,860 | 23.8 K to 26.9 K (+12.96 %) |
Apr 17 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 18.31 | 25,000 | 457,750 | 913,031 | 938 K to 913 K (-2.67 %) |
Apr 16 2020 | VIR | Vir Biotechnology, ... | SCANGOS GEORGE A | President and CEO | Buy | J | 29.56 | 236,806 | 6,999,985 | 4,713,559 | 4.5 M to 4.7 M (+5.29 %) |
Apr 16 2020 | VIR | Vir Biotechnology, ... | SCANGOS GEORGE A | President and CEO | Sell | J | 29.56 | 236,806 | 6,999,985 | 1,907,329 | 2.1 M to 1.9 M (-11.04 %) |
Apr 09 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 18.35 | 7,065 | 129,643 | 938,031 | 945.1 K to 938 K (-0.75 %) |
Apr 09 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 18.25 | 16,435 | 299,939 | 945,096 | 961.5 K to 945.1 K (-1.71 %) |
Apr 09 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 18.35 | 7,065 | 129,643 | 938,031 | 945.1 K to 938 K (-0.75 %) |
Apr 09 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 18.25 | 16,435 | 299,939 | 945,096 | 961.5 K to 945.1 K (-1.71 %) |
Apr 02 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 18.06 | 1,500 | 27,090 | 961,531 | 963 K to 961.5 K (-0.16 %) |
Feb 21 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 20.73 | 50,000 | 1,036,500 | 963,031 | 1 M to 963 K (-4.94 %) |
Feb 12 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 20.02 | 21,000 | 420,420 | 1,013,031 | 1 M to 1 M (-2.03 %) |
Feb 12 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 20.14 | 4,000 | 80,560 | 1,034,031 | 1 M to 1 M (-0.39 %) |
Jan 24 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 19.75 | 25,000 | 493,750 | 1,038,031 | 1.1 M to 1 M (-2.35 %) |
Jan 17 2020 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 20.39 | 25,000 | 509,750 | 1,063,031 | 1.1 M to 1.1 M (-2.30 %) |
Dec 27 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 18.25 | 25,000 | 456,250 | 1,090,531 | 1.1 M to 1.1 M (-2.24 %) |
Dec 27 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Gift | G | 0.00 | 12,500 | 0 | 1,115,531 | 1.1 M to 1.1 M (-1.11 %) |
Aug 02 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 21.23 | 6,050 | 128,442 | 1,128,031 | 1.1 M to 1.1 M (-0.53 %) |
Aug 02 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 20.48 | 33,950 | 695,296 | 1,134,081 | 1.2 M to 1.1 M (-2.91 %) |
Jul 03 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 21.58 | 40,000 | 863,200 | 1,168,031 | 1.2 M to 1.2 M (-3.31 %) |
Jun 05 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 20.00 | 15,000 | 300,000 | 1,208,031 | 1.2 M to 1.2 M (-1.23 %) |
Jun 05 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 19.61 | 25,000 | 490,250 | 1,223,031 | 1.2 M to 1.2 M (-2.00 %) |
May 24 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | A | 19.77 | 42,641 | 843,013 | 42,641 | |
May 22 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | M | 4.57 | 15,000 | 68,550 | 0 | |
May 22 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Buy | M | 4.57 | 15,000 | 68,550 | 1,248,031 | 1.2 M to 1.2 M (+1.22 %) |
May 03 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 20.00 | 15,000 | 300,000 | 1,233,031 | 1.2 M to 1.2 M (-1.20 %) |
May 03 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 19.75 | 25,000 | 493,750 | 1,248,031 | 1.3 M to 1.2 M (-1.96 %) |
Apr 03 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 25.03 | 5,000 | 125,150 | 1,273,031 | 1.3 M to 1.3 M (-0.39 %) |
Apr 03 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 24.02 | 40,000 | 960,800 | 1,278,031 | 1.3 M to 1.3 M (-3.03 %) |
Mar 22 2019 | A | AGILENT TECHNOLOGI ... | SCANGOS GEORGE A | Director | Grant | A | 82.00 | 1,255 | 102,910 | 23,699 | 22.4 K to 23.7 K (+5.59 %) |
Mar 22 2019 | A | AGILENT TECHNOLOGI ... | SCANGOS GEORGE A | Director | Grant | A | 82.00 | 2,823 | 231,486 | 22,444 | 19.6 K to 22.4 K (+14.39 %) |
Mar 15 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 25.00 | 5,000 | 125,000 | 1,318,031 | 1.3 M to 1.3 M (-0.38 %) |
Mar 01 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 22.66 | 40,000 | 906,400 | 1,323,031 | 1.4 M to 1.3 M (-2.93 %) |
Feb 01 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 23.53 | 40,000 | 941,200 | 1,363,031 | 1.4 M to 1.4 M (-2.85 %) |
Jan 04 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 20.00 | 96 | 1,920 | 1,403,031 | 1.4 M to 1.4 M (-0.01 %) |
Jan 04 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 19.64 | 39,904 | 783,715 | 1,403,127 | 1.4 M to 1.4 M (-2.77 %) |
Jan 04 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Gift | G | 0.00 | 9,300 | 0 | 1,443,031 | 1.5 M to 1.4 M (-0.64 %) |
Jan 04 2019 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Gift | G | 0.00 | 4,650 | 0 | 1,452,331 | 1.5 M to 1.5 M (-0.32 %) |
Dec 03 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 21.16 | 40,000 | 846,400 | 1,456,981 | 1.5 M to 1.5 M (-2.67 %) |
Dec 03 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 21.16 | 40,000 | 846,400 | 1,456,981 | 1.5 M to 1.5 M (-2.67 %) |
Dec 03 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 20.00 | 8,500 | 170,000 | 1,496,981 | 1.5 M to 1.5 M (-0.56 %) |
Dec 03 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 20.00 | 8,500 | 170,000 | 1,496,981 | 1.5 M to 1.5 M (-0.56 %) |
Dec 03 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 20.00 | 6,500 | 130,000 | 1,505,481 | 1.5 M to 1.5 M (-0.43 %) |
Dec 03 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 20.00 | 6,500 | 130,000 | 1,505,481 | 1.5 M to 1.5 M (-0.43 %) |
Nov 02 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 14.14 | 10,000 | 141,400 | 1,511,981 | 1.5 M to 1.5 M (-0.66 %) |
Nov 02 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 15.00 | 15,000 | 225,000 | 1,521,981 | 1.5 M to 1.5 M (-0.98 %) |
Oct 03 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 17.86 | 25,000 | 446,500 | 1,536,981 | 1.6 M to 1.5 M (-1.60 %) |
Sep 26 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 16.85 | 25,000 | 421,250 | 1,561,981 | 1.6 M to 1.6 M (-1.58 %) |
Aug 10 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | M | 4.42 | 33,333 | 147,332 | 0 | |
Aug 10 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | M | 5.04 | 75,000 | 378,000 | 0 | |
Aug 10 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Buy | M | 4.42 | 33,333 | 147,332 | 1,586,981 | 1.6 M to 1.6 M (+2.15 %) |
Aug 10 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Buy | M | 5.04 | 75,000 | 378,000 | 1,553,648 | 1.5 M to 1.6 M (+5.07 %) |
Aug 10 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | M | 4.42 | 33,333 | 147,332 | 0 | |
Aug 10 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | M | 5.04 | 75,000 | 378,000 | 0 | |
Aug 10 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Buy | M | 4.42 | 33,333 | 147,332 | 1,586,981 | 1.6 M to 1.6 M (+2.15 %) |
Aug 10 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Buy | M | 5.04 | 75,000 | 378,000 | 1,553,648 | 1.5 M to 1.6 M (+5.07 %) |
May 24 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | A | 20.50 | 31,167 | 638,924 | 31,167 | |
May 16 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | M | 11.66 | 15,000 | 174,900 | 0 | |
May 16 2018 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Buy | M | 11.66 | 15,000 | 174,900 | 1,478,648 | 1.5 M to 1.5 M (+1.02 %) |
Mar 23 2018 | A | AGILENT TECHNOLOGI ... | SCANGOS GEORGE A | Director | Grant | A | 67.47 | 1,438 | 97,022 | 19,574 | 18.1 K to 19.6 K (+7.93 %) |
Mar 23 2018 | A | AGILENT TECHNOLOGI ... | SCANGOS GEORGE A | Director | Grant | A | 67.47 | 2,876 | 194,044 | 18,136 | 15.3 K to 18.1 K (+18.85 %) |
May 26 2017 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | A | 19.57 | 23,491 | 459,719 | 23,491 | |
Mar 17 2017 | A | AGILENT TECHNOLOGI ... | SCANGOS GEORGE A | Director | Grant | A | 53.05 | 3,866 | 205,091 | 15,253 | 11.4 K to 15.3 K (+33.95 %) |
Dec 07 2016 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | M | 8.99 | 356 | 3,200 | 0 | |
Dec 07 2016 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | M | 8.99 | 357,976 | 3,218,204 | 356 | |
Dec 07 2016 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 17.90 | 176 | 3,150 | 1,463,648 | 1.5 M to 1.5 M (-0.01 %) |
Dec 07 2016 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Buy | M | 8.99 | 356 | 3,200 | 1,463,824 | 1.5 M to 1.5 M (+0.02 %) |
Dec 07 2016 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Sell | S | 17.81 | 204,718 | 3,646,028 | 1,463,468 | 1.7 M to 1.5 M (-12.27 %) |
Dec 07 2016 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Buy | M | 8.99 | 357,976 | 3,218,204 | 1,668,186 | 1.3 M to 1.7 M (+27.32 %) |
Jul 22 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 280.00 | 157 | 43,960 | 54,779 | 54.9 K to 54.8 K (-0.29 %) |
Jun 06 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 290.00 | 842 | 244,180 | 54,936 | 55.8 K to 54.9 K (-1.51 %) |
Jun 02 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 287.97 | 487 | 140,241 | 55,778 | 56.3 K to 55.8 K (-0.87 %) |
Jun 02 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 290.00 | 3,368 | 976,720 | 56,265 | 59.6 K to 56.3 K (-5.65 %) |
May 27 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 280.00 | 157 | 43,960 | 59,633 | 59.8 K to 59.6 K (-0.26 %) |
May 26 2016 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | A | 6.30 | 40,000 | 252,000 | 40,000 | |
May 04 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 274.74 | 487 | 133,798 | 59,790 | 60.3 K to 59.8 K (-0.81 %) |
Apr 07 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 280.00 | 157 | 43,960 | 60,277 | 60.4 K to 60.3 K (-0.26 %) |
Apr 05 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 258.83 | 487 | 126,050 | 60,434 | 60.9 K to 60.4 K (-0.80 %) |
Mar 03 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 261.37 | 487 | 127,287 | 60,921 | 61.4 K to 60.9 K (-0.79 %) |
Feb 25 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | J | 0.00 | 5,884 | 0 | 17,702 | |
Feb 25 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | M | 0.00 | 2,964 | 0 | 23,586 | |
Feb 25 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 258.99 | 1,395 | 361,291 | 61,417 | 62.8 K to 61.4 K (-2.22 %) |
Feb 25 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Buy | M | 0.00 | 2,964 | 0 | 62,812 | 59.8 K to 62.8 K (+4.95 %) |
Feb 24 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | A | 0.00 | 40,460 | 0 | 40,460 | |
Feb 19 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 256.16 | 487 | 124,750 | 59,848 | 60.3 K to 59.8 K (-0.81 %) |
Feb 17 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | J | 0.00 | 5,982 | 0 | 10,502 | |
Feb 17 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | M | 0.00 | 9,189 | 0 | 9,182 | |
Feb 17 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | M | 0.00 | 4,512 | 0 | 16,484 | |
Feb 17 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 247.22 | 5,359 | 1,324,852 | 60,335 | 65.7 K to 60.3 K (-8.16 %) |
Feb 17 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Grant | A | 0.00 | 11,390 | 0 | 65,694 | 54.3 K to 65.7 K (+20.97 %) |
Feb 17 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 247.22 | 4,324 | 1,068,979 | 54,304 | 58.6 K to 54.3 K (-7.38 %) |
Feb 17 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Buy | M | 0.00 | 9,189 | 0 | 58,628 | 49.4 K to 58.6 K (+18.59 %) |
Feb 17 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 247.22 | 2,132 | 527,073 | 49,439 | 51.6 K to 49.4 K (-4.13 %) |
Feb 17 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Buy | M | 0.00 | 4,512 | 0 | 51,571 | 47.1 K to 51.6 K (+9.59 %) |
Feb 10 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | M | 0.00 | 11,274 | 0 | 0 | |
Feb 10 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Payment of Exercise | F | 249.99 | 5,305 | 1,326,197 | 47,059 | 52.4 K to 47.1 K (-10.13 %) |
Feb 10 2016 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Buy | M | 0.00 | 11,274 | 0 | 52,364 | 41.1 K to 52.4 K (+27.44 %) |
Mar 18 2016 | A | AGILENT TECHNOLOGI ... | SCANGOS GEORGE A | Director | Grant | A | 39.29 | 4,704 | 184,820 | 11,378 | 6.7 K to 11.4 K (+70.48 %) |
Jan 05 2016 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Grant | A | 0.00 | 6,383 | 0 | 1,310,210 | 1.3 M to 1.3 M (+0.49 %) |
Jun 02 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 398.87 | 1,362 | 543,261 | 41,090 | 42.5 K to 41.1 K (-3.21 %) |
May 28 2015 | EXEL | EXELIXIS, INC. | SCANGOS GEORGE A | Director | Option Exercise | A | 3.13 | 40,000 | 125,200 | 40,000 | |
May 05 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 377.52 | 1,362 | 514,182 | 42,452 | 43.8 K to 42.5 K (-3.11 %) |
Apr 02 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 423.20 | 1,362 | 576,398 | 43,814 | 45.2 K to 43.8 K (-3.01 %) |
Mar 20 2015 | A | AGILENT TECHNOLOGI ... | SCANGOS GEORGE A | Director | Grant | A | 42.21 | 4,311 | 181,967 | 6,666 | 2.4 K to 6.7 K (+183.06 %) |
Mar 16 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 412.69 | 537 | 221,613 | 45,176 | 45.7 K to 45.2 K (-1.17 %) |
Mar 03 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Sell | S | 410.67 | 825 | 338,803 | 45,713 | 46.5 K to 45.7 K (-1.77 %) |
Feb 25 2015 | IDPH | BIOGEN INC. | SCANGOS GEORGE A | Chief Executive Off ... | Option Exercise | A | 0.00 | 26,550 | 0 | 26,550 |
Page: 1